Patient Registry Software Market Size, Share & Trend Report

Patient Registry Software Market Size, Share & Trend Analysis Report By Product, By Software, By Deployment, By Database, By Functionality, By End Use, And Segment Forecasts, 2019 To 2026

  • Published Date: ---
  • Base Year for Estimate: ---
  • Report ID: GVR6997
  • Format: Electronic (PDF)
  • Historical Data: ---
  • Number of Pages: 0

The global patient registry software market is poised to register significant growth over the forecast period. Increasing incidence of chronic diseases such as cancer, diabetes, cardiovascular diseases are fueling the demand for integrated registries for better treatment outcomes and new drug development.

On the basis of product, the patient registry software market is segmented into disease, health service and, product registry. The disease registry is further sub-segmented into cardiovascular, diabetes, cancer, rare disease, asthma and others. Once a medical device or a drug is approved by a regulatory authority, a registry is required for quality evaluation during post-approval phase in order to identify any adverse reaction and to enhance the understanding of product safety. Increasing clinical trials resulting in the extensive product pipeline will demand product registry, thereby, providing lucrative growth platform to this segment over the forecast period.

Supportive government initiative in order to improve the treatment outcomes is propelling the segment. For instance, in April 2019, Northgate Public Services (NPS) of the UK collaborated with Indian Society of Hip and Knee Surgeons (ISHKS) to launch Indian Joint Registry (IJP). This is intended to build and maintain the Indian Joint Registry (IJR) to store patient data efficiently and securely. Moreover, this platform is designed to enhance patient outcomes and insight into long term joint and procedural performance.

On the basis of software, standalone held the largest revenue share as of 2018, owing to its ease of usage tools and advanced features. Standalone software applications are meant to address only a specific register such as cardiovascular, rare disease, diabetes, cancer patient details. Hence, it is detail oriented and data retrieval is also quite easy. Moreover, the automatic upgrade feature of standalone helps to reduce IT overhead cost.

Web/cloud-based solution is expected to exhibit lucrative growth to the deployment model market segment over the forecast period owing to its advanced features such as real-time tracking and remote access to data. Moreover, integration in accordance with the standard guidelines is another advantage fueling the demand for this solution.

The commercial segment dominated the patient registry software market as of 2018, owing to data security as compared to the public database. Moreover, this software offers a couple of advantages such as a single point of contact for any business problem, timely software upgradation, and ease of use. The commercial systems allow data exchange among government research organizations such as CDC and central disease registries as well which is further boosting the growth.

On the basis of functionality, population health management dominated the market as of 2018. Increasing demand for solutions supporting value-based care delivery by stakeholders has resulted in a shift from Fee-for-Service (FFS) to a Value-based Payment (VBP) model. PHM helps to standardize physician approach, enhance clinical outcomes, and help to lessen the cost of the disease management which is further fueling the segment growth.

On the basis of end-use, the patient registry software market is segmented into government & third party, hospitals & medical practices, private payers, pharma & medical device companies, and research organizations. Implementation of patient registry software by the government in both developed and developing countries to decrease the disease burden is fueling the market growth.

North America dominated the global market in terms of revenue share in 2018. Increasing target population coupled with rising prevalence of diseases and rising need of population-based registries is propelling the growth in this region. Moreover, supportive government initiatives make this continent as a major contributor to the market. In order to make patient registry software more user interactive and clinical research-friendly, companies are constantly trying to develop better user-interactive software. For instance, in August 2019, IQVIA launched a new web-based solution for the enrollment of clinical trial information.

The industry is marked by the presence of various small and large industry players. The patient registry software market is competitive and highly fragmented. Some of the key market players include Phytel, Inc., McKesson Corporation, Quintiles, Dacima Software Inc., ImageTrend, Inc., IBM, IQVIA etc. 

Key questions answered by the report
Request for Customization

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified